Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.

doi:10.1016/j.ctarc.2026.101310

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.

Cancer treatment and research communications - 1 Jan 2026

Kosmidis Paris A, Kosmidis Thanos, Papadopoulou Kyriaki, Korfiatis Nikolaos, Vozikis Athanasios, Lampaki Sofia, Economopoulou Panagiota, Fountzila Elena, Christopoulou Athina, Samantas Epaminondas, Vagionas Anastasios, Mountzios Giannis Socrates, Gkoumas Georgios, Tsoukalas Nikolaos, Athanasiadis Ilias, Bafaloukos Dimitris, Panopoulos Chris, Koufaki Margarita Ioanna, Petrakis George, Fountzilas Georgios, Linardou Helena

Abstract excerpt

BACKGROUND: We report for the first time the molecular landscape and outcome associations from the prospective CLIMEDIN trial in Greece. METHODS: Two hundred patients with newly diagnosed advanced NSCLC (March 2022-October 2023) were enrolled and randomized to standard-of-care education versus additional automated, adverse-event-targeted digital interventions. Within this study baseline testing (EGFR, ALK, PD-L1)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to ALK gene

Share to Greece

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed

Identifiers

PMID: 42497607
DOI: 10.1016/j.ctarc.2026.101310

Genes

EGFR
KRAS
ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.PMID 42497607Read ↗

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).Semantic proximity Read ↗

Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.Semantic proximity Read ↗

Genomic Landscape of NSCLC in the Republic of IrelandSemantic proximity Read ↗

Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.Semantic proximity Read ↗

Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.Semantic proximity Read ↗

FIN-EGFRprint: a Finnish real-world study on treatments and outcomes in advanced NSCLC with common EGFR mutations.Semantic proximity Read ↗

Genomic Profile of Non-Small Cell Lung Cancer in a Spanish Cohort: A 2-Year Descriptive Study Using Next-Generation Sequencing.Semantic proximity Read ↗

Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS studySemantic proximity Read ↗

The Impact of Smoking Status on the Genomic Landscape of Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World StudySemantic proximity Read ↗

Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study.Semantic proximity Read ↗

Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.